Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiglucerase Pharmacokinetics in Gaucher Disease
NCT01951989Phase 2Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Nov 2012
- Primary completion
- Feb 2016
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of imiglucerase in Gaucher disease (GD), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
imiglucerase
03
Conditions
Gaucher disease (GD)
Beyond the preview
Go deeper on NCT01951989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951989.